Skip to main content
    S

    Scisparc Ltd (SPRC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.33
    -0.02 (-6.34%)

    Market Cap: $869,840

    Last updated: Nov 17, 2026 at 10:58 AM ET

    Scisparc Ltd (SPRC) Financials: Revenue, Profit and Cash Flow

    Updated Jul 29, 2026. Financial statements from company filings, amounts in US dollars.

    Scisparc reported revenue of $856.00K for the fiscal year ended Dec 31, 2025, down 34.5% from the year before. That year, net income was -$12.18M with a net margin of -1422.8%, operating cash flow was -$4.14M and free cash flow was -$4.14M. The quarter ended Jun 30, 2026 had revenue of $284.00K and net income of -$5.37M.

    Revenue and Margins

    Over the 8 years to Dec 2025, revenue grew from $487.00K, a compound annual rate of 7.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$856.00K-34.5%73.7%-1022.1%-1422.8%
    Dec 2024$1.31M-54.6%38.7%-560.2%-481.2%
    Dec 2023$2.88M+113.7%76.3%-200.5%-177.9%
    Dec 2022$1.35M+26.0%76.1%-547.9%-192.4%
    Dec 2021$1.07M+94.4%96.9%-539.6%-542.7%
    Dec 2020$550.00K+10.4%70.2%-598.7%-637.6%
    Dec 2019$498.00K-40.6%64.1%-824.9%-1076.7%
    Dec 2018$838.00K+72.1%82.5%-1159.2%-1017.1%
    Dec 2017$487.00KN/A99.0%-1181.5%-1282.1%
    Dec 2016N/AN/AN/AN/AN/A
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$856.00K$1.31M$2.88M$1.35M$1.07M$550.00K$498.00K$838.00K$487.00KN/A
    Cost of revenue$225.00K$800.00K$683.00K$322.00K$33.00K$164.00K$179.00K$147.00K$5.00KN/A
    Gross profit$631.00K$506.00K$2.20M$1.02M$1.04M$386.00K$319.00K$691.00K$482.00KN/A
    Research and development$2.19M$1.81M$1.64M$2.80M$1.99M$649.00K$1.64M$2.71M$2.02M$738.83K
    Operating income-$8.75M-$7.32M-$5.77M-$7.38M-$5.77M-$3.29M-$4.11M-$9.71M-$5.75MN/A
    Net income-$12.18M-$6.28M-$5.12M-$2.59M-$5.80M-$3.51M-$5.36M-$8.52M-$6.24MN/A
    EBITDAN/A-$6.97M-$5.31M-$2.35M-$5.74M-$2.39M-$3.73M-$6.93M-$5.75M-$2.00M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Revenue$284.00K$395.00K$461.00K$466.00K$840.00K$907.00K$1.97M$1.35MN/AN/AN/A$1.07M
    Gross profit$212.00K$226.00K$171.00K$32.00K$474.00K$323.00K$705.00K$1.02MN/AN/A-$21.00K$1.04M
    Operating income-$4.89M$402.00K-$9.15M-$10.84M$3.53M$3.85M-$2.97M-$3.47MN/AN/A-$4.81M-$3.14M
    Net income-$5.37M-$2.85M-$9.33M-$2.84M-$3.44M-$2.24M-$2.88M$3.17MN/AN/A-$5.76M-$3.14M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $366.00K by $4.22M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$7.62M$10.35M$11.18M$10.61M$9.92M$2.56M$1.15M$4.56M$9.57M$1.24M
    Current assets$5.44M$7.50M$6.45M$4.51M$9.82M$2.55M$955.00K$2.43M$9.50M$803.83K
    Cash and equivalents$4.59M$1.54M$2.08M$3.57M$6.88M$1.95M$870.00K$1.49M$9.20M$675.40K
    Total liabilities$2.48M$1.41M$1.59M$4.16M$1.77M$1.13M$1.14M$4.48M$1.18M$672.02K
    Short-term debt$366.00K$37.00K$52.00K$27.00K$486.00K$188.00K$406.00K$1.15MN/AN/A
    Shareholder equity$4.24M$8.15M$7.61M$6.45M$8.14M$1.43M$14.00K$185.00K$8.13M$572.71K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Jun 2023
    Total assets$18.49M$7.62M$7.62M$5.14M$5.14M$10.35M$10.35M$10.48M$10.48M$11.18M$11.18M$9.89M
    Total liabilities$7.22M$2.48M$2.48M$5.22M$5.22M$1.41M$1.41M$1.83M$1.83M$1.59M$1.59M$3.11M
    Cash and equivalents$4.44M$4.59M$4.59M$1.54M$1.54M$1.54M$1.54M$252.00K$252.00K$2.08M$2.08M$2.08M
    Shareholder equity$3.94M$4.24M$4.24M-$782.00K-$782.00K$8.15M$8.15M$6.92M$6.92M$7.61M$7.61M$4.10M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$4.14M-$5.10M-$5.89M-$7.92M-$5.06M-$4.31M-$4.70M-$7.13M-$4.58MN/A
    Capital expenditures$0$0$0$4.87M$35.00K$35.00K$1.00K$17.00K$44.00KN/A
    Free cash flow-$4.14M-$5.10M-$5.89M-$12.79M-$5.10M-$4.34M-$4.70M-$7.15M-$4.62MN/A
    Investing cash flow-$1.40M-$1.63M-$1.11M-$7.08M-$70.00K$24.00K$1.27M-$2.09M-$53.00KN/A
    Financing cash flow$8.59M$6.19M$5.50M$11.70M$10.06M$5.36M$2.80M$1.54M$13.18M$563.87K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Jun 2023Mar 2023Dec 2022
    Operating cash flow-$3.56M-$2.28M-$1.86M-$2.91M-$2.20M-$2.65M-$3.23M-$5.73M-$2.86M
    Capital expenditures$0$0$0$1.00K$1.00K$0$0$8.00K$4.00K
    Free cash flow-$3.56M-$2.28M-$1.86M-$2.91M-$2.20M-$2.65M-$3.23M-$5.74M-$2.87M
    Last 9 quarters

    Frequently Asked Questions About SPRC

    What is Scisparc's annual revenue?

    Scisparc reported revenue of $856.00K for the fiscal year ended Dec 31, 2025.

    How fast is Scisparc's revenue growing?

    Revenue was down 34.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -14.0%.

    Is Scisparc profitable?

    No. Scisparc reported net income of -$12.18M for the fiscal year ended Dec 31, 2025, with a net margin of -1422.8%.

    How much free cash flow does SPRC generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$4.14M minus capital expenditures of $0 produced free cash flow of -$4.14M.

    How much debt does Scisparc have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $366.00K and cash and equivalents of $4.59M.